Recent Updates
Recently added Catalysts
ILMN Positive Sentiment Score: 75/100

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics Illumina Inc. (NASDAQ: ILMN), aligned with its commitments to advance the power of genomics, today published its annual Corporate Social...

Tuesday, June 10, 2025 2 min read
Key Takeaway: Illumina Inc. has released its 2024 Corporate Social Responsibility (CSR) report, highlighting its commitment to advancing health equity through genomics. CEO Jacob Thaysen mentioned that while innovation has led to significant breakthroughs, access to these advancements is crucial. The report showcases progress in four key areas of the company's CSR strategy, aimed at benefiting patients, communities, employees, and the environment. Illumina continues to position itself as a leader in DNA sequencing and array-based technologies.

Market Sentiment Analysis

POSITIVE FACTORS

  • Illumina emphasizes its commitment to improving human health through genomics.
  • The CSR strategy aims to enhance access to genomics technologies.
  • Progress is shown in four key areas of the CSR program.

Full Press Release Details

"At Illumina, we work relentlessly in our mission to improve human health by unlocking the power of the genome, and our CSR strategy is an essential part of that," said Jacob Thaysen , CEO of Illumina. "Our innovation has driven incredible breakthroughs—but those breakthroughs only matter if they can be accessed. Our CSR efforts are designed to drive greater access to genomics technologies and improve health equity for billions of people around the world. We continue to take meaningful steps to champion patients, communities, employees, and the planet as we work to create a healthier and more sustainable future."
2024 highlights
Illumina's CSR program is rooted in four key areas, and the company's CSR report demonstrates progress made in 2024 in each:
The full report is available on Illumina's CSR website .
About Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit illumina.com and connect with us on X , Facebook , LinkedIn , Instagram , TikTok , and YouTube .
Investors: Brian Blanchett +1.858.291.6421 [email protected]
Media: Christine Douglass [email protected]
SOURCE Illumina, Inc.

21 %

Frequently Asked Questions

What is Illumina's main mission?

Illumina aims to improve human health by unlocking the power of the genome.

How does Illumina support health equity?

Illumina’s CSR efforts focus on increasing access to genomic technologies globally.

What areas does Illumina's CSR program cover?

The CSR program is centered on four key areas to promote health equity.

Where can I find Illumina's CSR report?

The full CSR report is available on Illumina's CSR website.

What markets does Illumina serve?

Illumina serves research, clinical, and applied markets in DNA sequencing.

Tags: ILMN Viatris Investor Conferences Healthcare Illumina corporate social responsibility genomics health equity DNA sequencing
Last updated: Jun 10, 2025